Liliane Andrade Chebli

7PUBLICATIONS
65CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 19, 2025
Tofacitinib for ulcerative colitis in Brazil: a multicenter observational study on effectiveness and safety.

Rogério Serafim Parra, Renata de Sá Brito Fróes, Daniela Oliveira Magro

|Apr 29, 2024
Effectiveness and Safety of Ustekinumab for Ulcerative Colitis: A Brazilian Multicentric Observational Study.

Rogério Serafim Parra, Júlio Maria Fonseca Chebli, Matheus Freitas Cardoso de Azevedo

|Oct 20, 2023
Vedolizumab in Mild-to-Moderate Crohn's Disease Patients Naïve to Biological Therapy: A Multicentric Observational Study.

Adriana Zanoni Dotti, Daniela Oliveira Magro, Eduardo Garcia Vilela

|Mar 30, 2023
SECOND BRAZILIAN CONSENSUS ON THE MANAGEMENT OF CROHN'S DISEASE IN ADULTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).

Marcello Imbrizi, Júlio Pinheiro Baima, Matheus Freitas Cardoso de Azevedo

|Apr 28, 2021
BRAZILIAN IBD STUDY GROUP POSITION STATEMENT ON SARS-COV2 VACCINATION.

Natália Sousa Freitas Queiroz, Fábio Vieira Teixeira, Caio Cesar Furtado Freire

Pageof 2